BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that ReceptoPharm had commenced its Phase IIb clinical trial in subjects with Adrenomyeloneuropathy (AMN).
